Feedback plc Navigates NHS Changes with Optimism and Strategic Flexibility

An update from Feedback ( (GB:FDBK) ) is now available.

Feedback plc has announced a trading update for the year ending 31 May 2025, highlighting challenges due to changes in NHS funding and organizational structures, which have delayed expected contract awards. Despite a projected revenue decline to £0.9m, the company remains financially stable with £6.6m in cash and investments. The shift in NHS funding models offers greater flexibility for Feedback’s contracting with Integrated Care Boards (ICBs), aligning with its G-Cloud pricing model. The company is optimistic about future opportunities, particularly in digitization and the NHS’s Neighbourhood Health model, and recently received recognition for its contributions to clinical redesign.

Spark’s Take on GB:FDBK Stock

According to Spark, TipRanks’ AI Analyst, GB:FDBK is a Neutral.

Feedback plc’s stock score reflects a mixture of strengths and challenges. The financial performance is bolstered by a strong balance sheet, but ongoing losses and cash flow issues remain concerns. Technical analysis indicators suggest a bearish trend, while valuation metrics highlight the difficulties in assessing the stock’s worth due to negative earnings. Corporate events provide a positive outlook, with strategic partnerships and funding supporting potential future growth.

To see Spark’s full report on GB:FDBK stock, click here.

More about Feedback

Feedback plc is a clinical infrastructure specialist that liberates data and knowledge from multiple healthcare IT systems to improve clinical workflows and patient outcomes. The company offers platforms like Bleepa® for communication and collaboration and CareLocker® for patient data access, serving both public and private healthcare markets, including the NHS, with a scalable software-as-a-service model.

YTD Price Performance: -4.11%

Average Trading Volume: 77,743

Technical Sentiment Signal: Buy

Current Market Cap: £7.67M

Find detailed analytics on FDBK stock on TipRanks’ Stock Analysis page.